ArticleLeukemia2026

Adaptor-mediated rewiring of FLT3 signaling engages p38 MAPK to sustain gilteritinib resistance in acute myeloid leukemia.

Long Shen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.